Healthcare -
Biotechnology - NASDAQ - US
$ 29.74
-2.14 %
$ 3.7 B
Market Cap
-14.65
P/E
APLS - TOTAL LIABILITIES
Total Liabilities APLS - Apellis Pharmaceuticals, Inc.
594 M
LAST VALUE
-6.73%
2 YEAR CAGR
69.43%
5 YEAR CAGR
96.94%
10 YEAR CAGR